Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
TG THERAPEUTICS, INC. market cap for the quarter ending 2026-08-03 was $7.07B, a 57.00% increase year-over-year.
TG THERAPEUTICS, INC. market cap for the quarter ending 2026-06-30 was $8.41B, a 47.86% increase year-over-year.
TG THERAPEUTICS, INC. market cap for the quarter ending 2026-05-01 was $5.18B, a 13.40% decline year-over-year.
TG THERAPEUTICS, INC. market cap for the quarter ending 2026-03-31 was $5.08B, a 18.49% decline year-over-year.
TG THERAPEUTICS, INC. market cap for fiscal 2026 was $7.07B.
TG THERAPEUTICS, INC. market cap for fiscal 2025 was $4.63B, a 1.20% decline from fiscal 2024.
TG THERAPEUTICS, INC. market cap for fiscal 2024 was $4.69B, a 81.36% increase from fiscal 2023.
TG THERAPEUTICS, INC. market cap for fiscal 2023 was $2.59B, a 49.35% increase from fiscal 2022.